Aptium Oncology is the leading solution for hospitals and oncology practices seeking to develop or enhance their oncology programs. With more than 25 years of experience working with premier institutions around the country, including NCI-designated programs, academic medical centers and community-based providers, the company offers a broad spectrum of oncology consulting and management expertise in the industry. Leveraging new treatments, surgical approaches and technologies, Aptium works with hospitals to develop highly differentiated cancer programs that drive clinical, operational and financial success. From tumor site program specialization to geographic expansion through satellite development, the company helps hospitals optimize their oncology service lines and build a distinct competitive edge in the cancer care market.
Aptium Oncology uses an integrated, multidisciplinary model, incorporating all levels of treatment into a comprehensive care program for cancer patients, including pharmaceutical management, psychosocial and nutrition services, and patient education programs.
Aptium Oncology is a subsidiary of AstraZeneca.
Specialties
Oncology consulting services, Cancer care program development, Oncology management services, Business plans and feasibility studies
